Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

Phase 2

Completed

Conditions: Precancerous Condition
Cervical Cancer

Interventions: Drug: imiquimod
Procedure: Ablative or excisional therapy

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 57

Registration Number: NCT00031759

Locations: 🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States
🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States

and more 5 locations

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Procedure: positron emission tomography
Procedure: radionuclide imaging
Radiation: fludeoxyglucose F 18

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 303

Registration Number: NCT00004138

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Lutheran General Hospital, Park Ridge, Illinois, United States

and more 20 locations

Genetic Markers in Patients With Colorectal Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: DNA stability analysis
Genetic: loss of heterozygosity analysis
Genetic: microsatellite instability analysis

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 675

Registration Number: NCT00014079

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Other: immunohistochemistry staining method
Procedure: lymphangiography
Procedure: sentinel lymph node biopsy
Procedure: therapeutic conventional surgery
Radiation: whole breast irradiation

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 4590

Registration Number: NCT00003854

Locations: 🇺🇸
York Cancer Center, York, Pennsylvania, United States
🇺🇸
Zale Lipshy University Hospital, Dallas, Texas, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

and more 113 locations

Irinotecan in Treating Aging Patients With Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: irinotecan hydrochloride

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 140

Registration Number: NCT00026195

Locations: 🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸
North Shore University Hospital, Manhasset, New York, United States
🇺🇸
Vermont Cancer Center, Burlington, Vermont, United States

and more 44 locations

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Phase 3

Completed

Conditions: Pain
Neurotoxicity

Interventions: Other: placebo
Drug: gabapentin

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 100

Registration Number: NCT00027963

Locations: 🇺🇸
CentraCare Health Plaza, Saint Cloud, Minnesota, United States
🇨🇦
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

and more 20 locations

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: gemcitabine hydrochloride
Drug: pemetrexed disodium

First Posted Date: 2003-01-27

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 59

Registration Number: NCT00006007

Locations: 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇨🇦
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
🇺🇸
CentraCare Health Plaza, Saint Cloud, Minnesota, United States

and more 21 locations

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2

Completed

Conditions: Kidney Cancer

Interventions: Biological: filgrastim
Biological: therapeutic allogeneic lymphocytes
Drug: cyclophosphamide
Drug: fludarabine phosphate
Drug: methotrexate
Drug: tacrolimus
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 36

Registration Number: NCT00027573

Locations: 🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
CCOP - Oklahoma, Tulsa, Oklahoma, United States
🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States

and more 3 locations

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

Phase 2

Completed

Conditions: Hot Flashes
Hot Flushes
Breast Cancer

Interventions: Dietary Supplement: soy protein
Dietary Supplement: isoflavones
Other: Placebo
Drug: Tamoxifen

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 112

Registration Number: NCT00031720

Locations: 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States
🇺🇸
Kingsbury Center for Cancer Care at Cheshire Medical Center, Keene, New Hampshire, United States

and more 11 locations

Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: filgrastim
Biological: rituximab
Drug: carmustine
Drug: cyclophosphamide
Drug: cytarabine
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: leucovorin calcium
Drug: methotrexate
Drug: prednisone
Drug: vincristine sulfate
Procedure: peripheral blood stem cell transplantation

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-19

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 79

Registration Number: NCT00020943

Locations: 🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States

and more 78 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy